Solution
Industries
Resources
About
Beacon Search

Osteoporosis Drugs: Technologies and Global Markets

Report Code: PHM064A

Publish Date: May 2010

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The global market for drugs that treat and prevent osteoporosis was estimated at $8 billion in 2009. This market is projected to grow at a compound annual growth rate (CAGR) of 3.8% to reach $9.7 billion in 2014.
  • The U.S. market for osteoporosis drugs is the largest geographical segment by revenues. This market was worth $3.9 billion in 2009 and is expected to increase at a compound annual growth rate (CAGR) of 4.5% to reach $4.8 billion in 2014.
  • The European Union (EU) market was valued at $2.5 billion in 2009 and is projected to increase at a compound annual growth rate (CAGR) of 2.5% to reach $2.8 billion in 2014.

INTRODUCTION

STUDY GOALS AND OBJECTIVES

This study intends to provide readers with an understanding of the global market for prescription drugs that treat and prevent osteoporosis. The study describes the industry structure and major participants in the osteoporosis drugs market, market dynamics and competitive aspects, current developments and future market trends, to assist in understanding the market and identifying areas of commercial interest and potential in osteoporosis. 
 
The study provides an assessment of the current market status, along with an analysis of the patient population, marketed drugs, market revenues, and company shares. The unmet needs of the osteoporosis market, and the challenges that companies must overcome to compete in this market, along with the future trends that shape the industry are also discussed. Future market revenues are forecast for the global market, major drug classes, and largest geographical regions. The study also reviews the compounds currently being investigated in clinical studies for the treatment of osteoporosis. 
 
REASONS FOR DOING THE STUDY
 
Osteoporosis is a skeletal disorder experiencing increasing prevalence globally, due mainly to the aging of the population and the increasing life expectancy worldwide. Osteoporosis fractures are a major cause of disability and morbidity, particularly among older people, and lead to decreased quality of life and increased costs due to disability and need for assisted living. The market for osteoporosis drugs is large, with global revenues exceeding $8.4 billion in 2008, and projected to grow. Prescription drugs for this indication could have great commercial success; four currently marketed drugs in this indication had global revenues of more than $1 billion at some point in their lifecycle. Additionally, several new drugs are projected to enter the market through 2014 and are expected to contribute to the overall osteoporosis market growth. 
 
SCOPE OF REPORT
 
The report intends to provide a current market snapshot and future developments in the osteoporosis drugs market covering the period from 2007 through 2014. The report describes the existing drug classes approved for these indications, including bisphosphonates, selective estrogen receptor modulators (SERMs), parathyroid hormones (PTHs), calcitonins, dual-action bone agents (DABAs), and hormone replacement therapies (HRTs). The pipeline of drugs in clinical trials for these indications is also presented and analyzed.
 
The report includes the following major sections:
 
  • Disease overview
  • Patient population analysis
  • Industry structure and competitive analysis, including tiers of competition, competitive factors, market unmet needs, challenges, and trends
  • Overall market revenue forecast, as well as revenue forecast by major drug classes and geographical regions
  • Global market shares and by geographical regions
  • In-depth analyses of current drug classes and profiles of major drugs
  • Reviews and analyses of compounds in clinical trials, with an emphasis on drugs in advanced stages of development
METHODOLOGY
 
The analyses and data presented in this report are based on information collected from a variety of industry sources, including pharmaceutical manufacturers and end users. Secondary information sources include company financials and documentation, Securities and Exchange Commission (SEC) filings, trade organizations and publications, online databases, and medical and scientific literature. 
 
The base year for analysis and forecast is 2008. Revenue forecasts are provided for the period of 2009 to 2014. The forecasts are based on a comprehensive analysis of a variety of market and product-specific factors, including historical, current, and future trends; existing and undiagnosed patient population; unmet market needs; existing products patent expiration dates; the threat of generic substitution; new market entrants; and their value proposition and differentiation. 
 
INTENDED AUDIENCE
 
This report provides information that is useful for business planners, market researchers, marketers, business developers, investors, venture capitalists, consultants, and anyone who wants to understand or invest in this market. The information is also useful for technology licensing and scientific research and development purposes.
 
 
 
 
 
 
INFORMATION SOURCES
 
The analysis and data presented in this report are based on information collected from a variety of industry sources, including the pharmaceutical manufacturers that currently market prescription drugs in this therapeutic area and research-based companies that develop new drug candidates for these indications, as well as end users of prescription drugs. Secondary information sources include company websites, financials, and other literature; U.S. SEC filings; trade organizations and publications; online databases; and medical and scientific literature. 
 
ANALYST CREDENTIALS
 
Adriana Rusu holds a Master of Business Administration and a Master of Arts in Chemistry degrees from the University of Arizona. She has more than 6 years of experience in market analysis and management consulting for the life-sciences industry. In her previous positions, Adriana consulted for various life-sciences industry players, including major pharmaceutical companies such as Pfizer, Johnson & Johnson, Novartis, and Merck. She has been quoted in various publications, including Pharma Drug Discovery, Chemistry and Industry, and Drug Discovery News. Adriana has also worked for several years in scientific research and development and quality control for the chemicals industry. 
 
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
 
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers
DISCLAIMER
 
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use. 
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter NamePagesMember Price
Full Report: Osteoporosis Drugs: Technologies and Global Markets197Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY3Free
Chapter- 3: OVERVIEW13Free
Chapter- 4: DISEASE OVERVIEW16Free
Chapter- 5: PATIENT POPULATION ANALYSIS13Free
Chapter- 6: INDUSTRY STRUCTURE AND COMPETITIVE ANALYSIS27Free
Chapter- 7: MARKETS BY DRUG CLASSES57Free
Chapter- 8: MARKETS BY GEOGRAPHICAL REGIONS15Free
Chapter- 9: PIPELINE REVIEW19Free
Chapter- 10: C. CRAMER & CO. GMBH22Free
Chapter- 11: NASCENT PATENT APPLICATION ACTIVITY 8Free

Related Reports

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 59

  • Summary Table: GLOBAL OSTEOPOROSIS DRUG MARKET BY GEOGRAPHIC REGION, THROUGH 2014
  • Table 1: MARKETED OSTEOPOROSIS DRUGS
  • Table 2: WHO CLASSIFICATION OF OSTEOPOROSIS
  • Table 3: MAYO CLINIC CLASSIFICATION OF OSTEOPOROSIS
  • Table 4: OSTEOPOROSIS DRUG CLASSES
  • Table 5: OSTEOPOROSIS DRUG CLASSES COMPARISON
  • Table 6: OSTEOPOROSIS-RELATED FRACTURES BY PATIENT’S GENDER, 2006
  • Table 7: ESTIMATED OSTEOPOROSIS PATIENT POPULATION:U.S. AND CANADA, 2010
  • Table 8: PREVALENCE OF OSTEOPOROSIS IN THE U.S., AGE ≥ 65 YEARS, 2004
  • Table 9: U.S. OSTEOPOROSIS-RELATED FRACTURES, 2005
  • Table 10: ESTIMATED OSTEOPOROSIS PATIENT POPULATION IN THE EU, 2009
Sample Report

Recent Reports

Global Markets for Infectious Disease Treatments

Published - Jul 2025 | Publisher - BCC Publishing | Code - PHM061F

The global market for infectious disease treatments is expected to grow from $72.5 billion in 2025 and is projected to reach $101 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.9% during the forecast period of 2025 to 2030.

Disease-Modifying Therapies for Alzheimer’s Disease: Global Markets

Published - Jun 2025 | Publisher - BCC Publishing | Code - PHM283A

This report provides an overview of the global and regional markets for disease-modifying therapies for Alzheimer’s disease. It includes global revenue ($ million) for base year data of 2024, estimates for 2025, and CAGR forecasts through 2030.

Global Markets for Allergy Diagnostics and Treatments

Published - Jun 2025 | Publisher - BCC Publishing | Code - PHM026D

The global market for allergy diagnostics and treatment is projected to grow from $67.8 billion in 2025 to $96.4 billion by the end of 2030, at a compound annual rate growth (CAGR) of 7.3% from 2025 through 2030.

Over-the-Counter (OTC) Drugs, and Vitamins & Dietary Supplements: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - PHM050D

The global market for over-the- counter (OTC) drugs, vitamins and dietary supplements is expected to grow from $276.9 billion in 2025 and is projected to reach $371.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2025 to 2030.

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

Published - May 2025 | Publisher - BCC Publishing | Code - PHM263B

This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

Top Trending Reports

Sensors: Technologies and Global Markets

Published - Jun 2025 | Publisher - BCC Publishing | Code - IAS006Q

The global market for sensors was valued at $195.1 billion in 2024 and is estimated to increase from $212.5 billion in 2025 to reach $323.3 billion by 2030, at a compound annual growth rate (CAGR) of 8.7% from 2025 through 2030.

Global Cell Line and Membrane Market

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO178B

The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.

Global Edge AI Market

Published - Jun 2025 | Publisher - BCC Publishing | Code - IFT310A

The global market for edge AI was valued at $8.7 billion in 2024 and is estimated to increase from $11.8 billion in 2025 to reach $56.8 billion by 2030, at a compound annual growth rate (CAGR) of 36.9% from 2025 through 2030.

Global Biochip Markets: Microarrays and Lab-on-a-Chip

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO049G

The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.

Water and Wastewater Treatment Technologies: Global Markets

Published - Jun 2025 | Publisher - BCC Publishing | Code - ENV008G

The global market for water and wastewater treatment technologies is expected to grow from $350.7 billion in 2025 and is projected to reach $591.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2025 to 2030.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Osteoporosis Drugs: Technologies and Global Markets
Customize This Report
Customize Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2025 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI: Your Say